**Author details**

Alpna R. Limaye1 , Lisa R. Dixon2 and Roberto J. Firpi1\*

\*Address all correspondence to: roberto.firpi@medicine.ufl.edu

1 Section of Hepatobiliary Diseases, Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Florida, Gainesville, FL, USA

[10] Cholongitas E, Quaglia A, Samonakis D, Senzolo M, Triantos C, Patch D, Leandro G, Dhillon AP, Burroughs AK. Transjugular liver biopsy: how good is it for accurate

Liver Biopsy After Liver Transplantation http://dx.doi.org/10.5772/52617 203

[11] Cholongitas E, Senzolo M, Standish R, Marelli L, Quaglia A, Patch D, Dhillon AP, Burroughs AK. A systematic review of the quality of liver biopsy specimens. Am J

[12] West J, Card TR. Reduced mortality rates following elective percutaneous liver biop‐

[13] Mells G, Neuberger J. Protocol liver allograft biopsies. Transplantation. 2008 Jun

[14] Ben-Ari Z, Neville L, Rolles K, Davidson B, Burroughs AK. Liver biopsy in liver transplantation: no additional risk of infections in patients with choledochojejunosto‐

[15] Sirivatanauksorn Y, Taweerutchana V, Limsrichamrern S, Kositamongkol P, Maha‐ withitwong P, Asavakarn S, Tovikkai C, Sanphasitvong V. Analysis of donor risk fac‐ tors associated with graft outcomes in orthotopic liver transplantation. Transplant

[16] Kakizoe S, Yanaga K, Starzl TE, Demetris AJ. Evaluation of protocol before trans‐ plantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury. Hepatology. 1990

[17] Gao Z. Seeking beyond rejection: an update on the differential diagnosis and a practi‐ cal approach to liver allograft biopsy interpretation. Adv Anat Pathol. 2009;16:97-117.

[18] Wang JT, Zhao HY, Liu YL. Portal vein thrombosis. Hepatobiliary Pancreat Dis Int.

[19] Shimamatsu K, Wanless IR. Role of ishchemia in causing apoptosis, atrophy, and

[20] Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, McGilvray ID, Thera‐ pondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liv‐

[21] Alves RC, Fonseca EA, Mattos CA, Abdalla S, Goncalves JE, Waisberg J. Predictive factors of early graft loss in living donor liver transplantation. Arg Gastroenterol.

[22] Demetris AJ, Kelly DM, Eghtesad B, Fontes P, Wallis Marsh J, Tom K, Tan HP, Shaw-Stiffel T, Boig L, Novelli P, Planinsic R, Fung JJ, Marcos A. Pathophysiologic observa‐ tions and histopathologic recognition of the portal hyperperfusion or small-for-size

nodular hyperplasia in human liver. Hepatology. 1997 Aug;26(2):343-50.

er transplantation. Liver Transpl. 2009 Dec;15(12):1776-82.

syndrome. Am J Surg Pathol. 2006 Aug;30(8):986-93.

histological interpretation? Gut. 2006 Dec;55(12):1789-94.

Clin Pathol. 2006 May;125(5):710-21.

my. J Hepatol. 1996 Mar;24(3):324-7.

Proc. 2012 Mar;44(2):320-3.

Jun;11(6):932-41.

2005 Nov;4(4):515-8.

2012 Jun;49(2):157-61.

27;85(12):1686-92.

sies. Gastroenterology. 2010 Oct;139(4):1230-7.

2 Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL, USA
